国际医学：优化资本结构把握银发经济机遇

Core Viewpoint - The company acknowledges ongoing financial pressures despite previous fundraising efforts, emphasizing the need for strategic adjustments to improve performance and capitalize on market opportunities [1] Group 1: Financial Performance - The company completed a 1 billion yuan private placement in January 2021 to support liquidity and repay bank loans [1] - The company has experienced a compound annual growth rate (CAGR) of 33.28% in revenue over the past three years, indicating growth in business scale [1] - Continuous losses have led to a cycle of borrowing and increased costs, necessitating urgent solutions to break this pattern [1] Group 2: Strategic Initiatives - The recent private placement aims to align with national policies and seize opportunities in the "silver economy" [1] - The company is focused on optimizing its capital structure and revitalizing existing assets to lay a solid foundation for future growth [1] - There is an emphasis on enhancing capabilities in the cancer treatment sector to meet future funding needs and improve operational sustainability [1]